National Human Genome Research Institute
- Country
- 🇺🇸United States
- Ownership
- Private, Subsidiary
- Established
- 1989-01-01
- Employees
- 251
- Market Cap
- -
- Website
- https://www.genome.gov
Clinical Trials
206
Trial Phases
4 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (32 trials with phase data)• Click on a phase to view related trials
Deciphering the Genetic Architecture of Autoimmune Diseases
- Conditions
- Autoimmune Diseases
- First Posted Date
- 2025-04-29
- Last Posted Date
- 2025-07-11
- Lead Sponsor
- National Human Genome Research Institute (NHGRI)
- Target Recruit Count
- 300
- Registration Number
- NCT06948110
- Locations
- 🇺🇸
National Human Genome Research Institute (NHGRI), Bethesda, Maryland, United States
🇵🇪Amazon Rainforest, Lima, Peru
Study to Understand the Genetic Risk of Developing an Immune Response After Blood Transfusions Among Individuals With Sickle Cell Disease
- Conditions
- Sickle Cell Disease
- First Posted Date
- 2025-04-25
- Last Posted Date
- 2025-06-27
- Lead Sponsor
- National Human Genome Research Institute (NHGRI)
- Target Recruit Count
- 50
- Registration Number
- NCT06944067
- Locations
- 🇺🇸
National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Childhood-Onset Essential Hypertension Natural History Study
- Conditions
- HypertensionEssential Hypertension
- First Posted Date
- 2025-01-16
- Last Posted Date
- 2025-06-13
- Lead Sponsor
- National Human Genome Research Institute (NHGRI)
- Target Recruit Count
- 2300
- Registration Number
- NCT06778239
- Locations
- 🇺🇸
National Institutes of Health Clinical Center, Bethesda, Maryland, United States
An Open-Label Phase 2 Study of N-Acetyl-D-Mannosamine (ManNAc) in Subjects With Primary Focal Segmental Glomerulosclerosis
- First Posted Date
- 2024-10-30
- Last Posted Date
- 2025-07-11
- Lead Sponsor
- National Human Genome Research Institute (NHGRI)
- Target Recruit Count
- 30
- Registration Number
- NCT06664814
- Locations
- 🇺🇸
National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Genetic Analysis of Uncommon Disease Presentations in Non-US Populations
- Conditions
- Undiagnosed DiseasesRare Diseases
- First Posted Date
- 2024-09-19
- Last Posted Date
- 2025-07-11
- Lead Sponsor
- National Human Genome Research Institute (NHGRI)
- Target Recruit Count
- 400
- Registration Number
- NCT06595940
- Locations
- 🇲🇺
University of Mauritius, Moka, Mauritius
- Prev
- 1
- 2
- 3
- 4
- 5
- 42
- Next
News
FDA Approves First Treatment for Alkaptonuria: Nitisinone Shows Clinical Benefits in Rare Metabolic Disorder
The FDA approved nitisinone (Harliku) as the first and only treatment for alkaptonuria, a rare genetic metabolic disorder affecting 1 in 250,000 to 1 million Americans.
Baylor College of Medicine to Study Telehealth Genetic Services for Underserved Newborns with $3.5 Million Grant
Baylor College of Medicine receives a $3.5 million grant from the National Human Genome Research Institute for the MAGNET program, aiming to improve genetic diagnoses for newborns in underserved Texas NICUs.